Perhaps inspired by the resurrection of "Game of Thrones" character Jon Snow, a U.S.-based biotech company is embarking on a trial to save clinically dead patients and bring them back to life. A combination of therapies are planned to be used on these people to make conscious again.
Telegraph said Bioquark Inc. has been granted permission to test 20 clinically dead patients who suffered traumatic brain injury for their ReAnima Project. The company is reportedly testing if a person's central nervous system can still be revived.
To do this, the same report explained that specialists will combine therapies including stem cell injection, laser deployment and nerve stimulation. Scientists will make sure that they will include participants who have been declared medically dead and only receiving life support through apparatuses.
Bioquark attempts to bring dead people back to life #innovation #amazing https://t.co/kBiB53sT6o
— Fabio Pittaluga (@FabioPittaluga3) May 5, 2016
"This represents the first trial of its kind and another step towards the eventual reversal of death in our lifetime," said Bioquark Inc. CEO Ira Pastor. "We hope to start recruiting patients immediately from this first site - we are working with the hospital now to identify families where there may be a religious or medical barrier to organ donation."
Pastor explained that they will utilize biologic regenerative medicine tools and other devices which could stimulate the central nervous system. She added that the results may come in a span of two to three months.
The Next Web added that this trial study will use previous researches that suggested that there is still blood flow and electrical activity in a person's body even after a brain cell death. This is said to be still enough for a person to operate normally when revived.
It was added in a Science Alert report that the trial experts will also look into other factors that can cause changes to a person's brain, tissues layers and even the skull. Once the testing starts, the scientists will see if there will be improvement's in the patients' blood pressure, respiration and pulse.
